Influence of Gelatinase B Polymorphic Variants and Its Serum Levels in Atherosclerosis

2012 ◽  
Vol 16 (8) ◽  
pp. 850-854 ◽  
Author(s):  
Kondapalli Mrudula Spurthi ◽  
Rajesh Kumar Galimudi ◽  
Gantala Srilatha ◽  
Sanjib Kumar Sahu ◽  
Pratibha Nallari ◽  
...  
2010 ◽  
Vol 104 (07) ◽  
pp. 165-171 ◽  
Author(s):  
Matthias Van Hul ◽  
Heléne Piccard ◽  
H. Roger Lijnen

SummaryThis study was performed to follow up on the observation that gelatinase A (MMP-2) deficiency impairs adipose tissue development in mice. The aim was to evaluate the role of its functional homologue gelatinase B (MMP-9) in adipose tissue growth. MMP-9 antigen levels were determined in lean and in obese women before and after weight loss. MMP-9-deficient mice and wild-type littermates (genetic background 50% 129sv : 50% CDI or 99.975% C57Bl/6, ten generations backcrossed into C57Bl/6 background) were kept on a high-fat diet (HFD) for 15 weeks. Subcutaneous and gonadal fat pads were analysed in terms of weight and size/density of adipocytes and blood vessels. Obese women had higher MMP-9 serum levels than lean controls (383 ± 29 vs. 304 ± 27 ng/ml, p = 0.02); after weight reduction MMP-9 levels dropped to 334 ± 17 ng/ml (p = 0.1 vs. obese). However, MMP-9-deficient and littermate wild-type mice kept on HFD were indistinguishable in terms of body and fat weight. No effect of MMP-9 deficiency was observed on size or density of adipocytes or blood vessels in subcutaneous or gonadal fat depots. Similar observations were made when mice were kept on normal chow. In conclusion, in lean and obese women, body mass index correlates positively with MMP-9 serum levels (p < 0.0001). However, MMP-9 does not seem to play a major role in adipose tissue development in murine models of diet-induced obesity.


Author(s):  
Tanya Tacheva ◽  
Dimo Dimov ◽  
Yanitsa Zhelyazkova ◽  
Denitsa Vlaykova ◽  
Georgi Beev ◽  
...  
Keyword(s):  

2020 ◽  
Vol 69 (1) ◽  
pp. 27-36
Author(s):  
Evgeny K. Komarov ◽  
Elena A. Mikhnina ◽  
Natalia S. Osinovskaya

The CYP17A1 gene encodes the most important stages of sex steroid biosynthesis by the adrenal glands and ovaries. The objective of this study was to evaluate the hormonal and metabolic status of patients with hyperandrogenia and the CYP17A1 rs743572 gene polymorphism. We examined 106 women with polycystic ovary syndrome androgen phenotypes A, B, and C and 28 women with latent non-classic congenital adrenal hyperplasia. It was found that there were no significant differences in the frequency of CYP17A1 alleles and genotypes between the three phenotype groups of patients with polycystic ovary syndrome. Body mass index and insulin resistance after glucose loading were comparable in individuals with these phenotypes of polycystic ovary syndrome. The CYP17A1 gene polymorphism in patients with different polycystic ovary syndrome phenotypes and in individuals with latent non-classic congenital adrenal hyperplasia did not associate with the concentration of estradiol and androgens in the blood. Neither did LH / FSH ratio differ between groups with different allelic variants of the CYP17A1 gene. These results show that patients with different polycystic ovary syndrome phenotypes do not require differentiated therapy. Serum levels of DHEA-S and cortisol were elevated in 38.7% of women with polycystic ovary syndrome without non-classic congenital adrenal hyperplasia, which indicates an adrenal cause of hyperandrogenia. We suppose that in the diagnosis of polycystic ovary syndrome, it is necessary to define not only phenotypes, but also a suprarenal source of androgens. The therapy of these patients may require application of corticosteroids besides the usual methods in planning of pregnancy.


2001 ◽  
Author(s):  
PA Klimiuk ◽  
S Sierakowski ◽  
R Latosiewicz ◽  
B Cylwik ◽  
J Skowronski ◽  
...  

Author(s):  
Julio H. Garcia ◽  
Janice P. Van Zandt

Repeated administration of methyl alcohol to Rhesus monkeys (Maccaca mulata) by intragastric tube resulted in ultrastructural abnormalities of hepatocytes, which persisted in one animal twelve weeks after discontinuation of the methyl alcohol regime. With dosages ranging between 3.0 to 6.0 gms. of methanol per kg. of body weight, the serum levels attained within a few hours averaged approximately 475 mg. per cent.


1998 ◽  
Vol 5 (1) ◽  
pp. 142A-142A
Author(s):  
S SPANDORFER ◽  
A KOWALIK ◽  
H LIU ◽  
G SCHATTMAN ◽  
L VEECK ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document